Sumitomo Life Insurance Co. Reduces Position in Xilinx, Inc. (XLNX)

Share on StockTwits

Sumitomo Life Insurance Co. reduced its position in shares of Xilinx, Inc. (NASDAQ:XLNX) by 12.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 18,505 shares of the programmable devices maker’s stock after selling 2,559 shares during the period. Sumitomo Life Insurance Co.’s holdings in Xilinx were worth $2,346,000 at the end of the most recent reporting period.

Several other hedge funds have also recently bought and sold shares of XLNX. Lindbrook Capital LLC purchased a new stake in shares of Xilinx during the 4th quarter worth about $25,000. Ropes Wealth Advisors LLC lifted its position in shares of Xilinx by 42.8% in the 4th quarter. Ropes Wealth Advisors LLC now owns 357 shares of the programmable devices maker’s stock worth $30,000 after acquiring an additional 107 shares during the period. Proficio Capital Partners LLC lifted its position in shares of Xilinx by 2,925.0% in the 4th quarter. Proficio Capital Partners LLC now owns 484 shares of the programmable devices maker’s stock worth $41,000 after acquiring an additional 468 shares during the period. TCI Wealth Advisors Inc. lifted its position in shares of Xilinx by 206.8% in the 1st quarter. TCI Wealth Advisors Inc. now owns 359 shares of the programmable devices maker’s stock worth $46,000 after acquiring an additional 242 shares during the period. Finally, Essex Savings Bank bought a new stake in shares of Xilinx in the 4th quarter worth approximately $68,000. 88.55% of the stock is currently owned by institutional investors and hedge funds.

In other news, SVP Mark Wadlington sold 2,241 shares of the stock in a transaction on Friday, April 12th. The stock was sold at an average price of $133.10, for a total value of $298,277.10. Following the completion of the transaction, the senior vice president now directly owns 1,834 shares in the company, valued at approximately $244,105.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.16% of the stock is owned by corporate insiders.

XLNX has been the subject of a number of research reports. SunTrust Banks raised their price objective on Xilinx to $102.00 and gave the stock a “hold” rating in a research report on Thursday, January 24th. BMO Capital Markets downgraded Xilinx from an “outperform” rating to a “market perform” rating and raised their target price for the stock from $100.00 to $125.00 in a research report on Monday, March 4th. Morgan Stanley raised their target price on Xilinx from $87.00 to $98.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 19th. Deutsche Bank raised their target price on Xilinx from $90.00 to $125.00 and gave the stock a “buy” rating in a research report on Wednesday. Finally, Cowen restated a “market perform” rating and set a $105.00 target price (up previously from $81.00) on shares of Xilinx in a research report on Thursday, January 24th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating, sixteen have issued a buy rating and two have given a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $108.43.

Shares of XLNX opened at $134.98 on Wednesday. The company has a quick ratio of 4.08, a current ratio of 4.38 and a debt-to-equity ratio of 0.46. Xilinx, Inc. has a 52-week low of $62.54 and a 52-week high of $135.75. The firm has a market capitalization of $34.17 billion, a price-to-earnings ratio of 47.70, a price-to-earnings-growth ratio of 2.88 and a beta of 1.18.

Xilinx (NASDAQ:XLNX) last issued its quarterly earnings data on Wednesday, January 23rd. The programmable devices maker reported $0.92 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.85 by $0.07. Xilinx had a return on equity of 34.82% and a net margin of 27.92%. The firm had revenue of $800.00 million during the quarter, compared to the consensus estimate of $770.65 million. During the same quarter in the previous year, the company posted $0.68 EPS. The business’s revenue for the quarter was up 33.6% compared to the same quarter last year. On average, equities research analysts forecast that Xilinx, Inc. will post 3.49 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by Fairfield Current and is the sole property of of Fairfield Current. If you are reading this piece on another website, it was illegally copied and reposted in violation of US & international copyright laws. The legal version of this piece can be read at https://www.fairfieldcurrent.com/news/2019/04/17/sumitomo-life-insurance-co-reduces-position-in-xilinx-inc-xlnx.html.

Xilinx Profile

Xilinx, Inc designs and develops programmable devices and associated technologies worldwide. Its programmable devices comprise integrated circuits (ICs) in the form of programmable logic devices (PLDs), such as programmable system on chips, and three dimensional ICs; adaptive compute acceleration platform; software design tools to program the PLDs; software development environments and embedded platforms; targeted reference designs; printed circuit boards; and intellectual property (IP) core licenses covering Ethernet, memory controllers, Interlaken, and peripheral component interconnect express interfaces, as well as domain-specific IP in the areas of embedded, digital signal processing and connectivity, and market-specific IP cores.

Featured Article: Certificate of Deposit (CD) For Risk Adverse Investors?

Institutional Ownership by Quarter for Xilinx (NASDAQ:XLNX)

Receive News & Ratings for Xilinx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xilinx and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply